Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Asthma

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 85 articles:
HTML format



Single Articles


    September 2022
  1. PERSSON C
    Creola bodies and pathogenesis of childhood asthma.
    Eur Respir J. 2022 Sep 30. pii: 13993003.01204-2022.
    PubMed    


  2. COLEMAN C, Khaleva E, Rattu A, Frankemolle B, et al
    Narrative Review to capture patients' perceptions and opinions about non-response and response to biological therapy for severe asthma.
    Eur Respir J. 2022 Sep 14. pii: 13993003.00837-2022.
    PubMed     Abstract available


  3. LIU J, Bowatte G, Pham J, Perret JL, et al
    Pre-pubertal smoke exposure of fathers and increased risk of offspring asthma: a possible transgenerational effect.
    Eur Respir J. 2022 Sep 14. pii: 13993003.00257-2022.
    PubMed    


  4. SORIANO JB
    Planetary respiratory health for asthma, rhinoconjunctivitis and eczema.
    Eur Respir J. 2022;60.
    PubMed    


  5. CHAN JSK, Murray RB, Price D
    Oral corticosteroids in asthma and beyond: moving forward.
    Eur Respir J. 2022;60.
    PubMed    


  6. PERREM L, Subbarao P
    Moving the dial on identifying endotypes of asthma from early life.
    Eur Respir J. 2022;60.
    PubMed    



  7. "Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma." M.K. Ali, R.Y. Kim, A.C. Brown et al. Eur Respir J 2020; 55: 1901340.
    Eur Respir J. 2022;60.
    PubMed    


  8. PAVORD ID
    Case-finding and diagnosis of obstructive airway diseases: the Dragons' Den experience.
    Eur Respir J. 2022;60.
    PubMed    


    August 2022
  9. CHAN R, Lipworth B
    Interactions between spirometry and oscillometry in patients with moderate to severe asthma.
    Eur Respir J. 2022 Aug 18. pii: 13993003.00543-2022.
    PubMed    


  10. LEE S, Prokopenko D, Kelly RS, Lutz S, et al
    Zinc finger protein 33B demonstrates sex-interaction with atopy-related markers in childhood asthma.
    Eur Respir J. 2022 Aug 11. pii: 13993003.00479-2022.
    PubMed     Abstract available


    July 2022
  11. PERRET JL, Dharmage SC, Bui DS
    Early life respiratory infections and pre-adult asthma: could there be an interaction and differential misclassification?
    Eur Respir J. 2022 Jul 26. pii: 13993003.01141-2022.
    PubMed    


  12. MCLOUGHLIN RF, Clark VL, Urroz PD, Gibson PG, et al
    Increasing physical activity in severe asthma: a systematic review and meta-analysis.
    Eur Respir J. 2022 Jul 26. pii: 13993003.00546-2022.
    PubMed     Abstract available


  13. VAN MEEL ER, Duijts L
    Reply to: "Early-life respiratory infections and pre-adult asthma: could there be an interaction and differential misclassification?"
    Eur Respir J. 2022 Jul 26. pii: 13993003.01384-2022.
    PubMed    


  14. MURPHY VE, Jensen ME, Holliday EG, Giles WB, et al
    Effect of asthma management with exhaled nitric oxide versus usual care on perinatal outcomes.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00298-2022.
    PubMed     Abstract available


  15. REDMOND C, Heaney LG, Chaudhuri R, Jackson DJ, et al
    Benefits of specialist severe asthma management: demographic and geographic disparities.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00660-2022.
    PubMed     Abstract available


  16. HOLMES J, McGarvey LP, Birring SS, Fletcher H, et al
    An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma.
    Eur Respir J. 2022 Jul 1. pii: 13993003.03205-2021.
    PubMed     Abstract available


  17. SALTER B, Zhao N, Son K, Suray Tan N, et al
    Airway autoantibodies are determinants of asthma severity.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00442-2022.
    PubMed     Abstract available


  18. WURZEL D, Licciardi PV
    Targeted strategies are needed to prevent childhood asthma.
    Eur Respir J. 2022;60.
    PubMed    


  19. WARK PAB
    We need to understand why viral infections lead to acute asthma.
    Eur Respir J. 2022;60.
    PubMed    


  20. VAN HULST G, Jorssen J, Jacobs N, Henket M, et al
    Reply: Ex vivo SOCS3 gene responsiveness to alarmins in eosinophils of mepolizumab-treated patients is as yet of unknown biological significance.
    Eur Respir J. 2022;60.
    PubMed    


  21. COUILLARD S
    The alarmin(g) effect of interleukin-5 blockade on residual eosinophil function is of clinical consequence.
    Eur Respir J. 2022;60.
    PubMed    


    June 2022

  22. "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma." Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, et al. Eur Respir J 2014; 43: 343-373.
    Eur Respir J. 2022;59.
    PubMed    


  23. BATEMAN ED, Price DB, Wang HC, Schonffeldt P, et al
    Reply to: Cause or consequence?
    Eur Respir J. 2022;59.
    PubMed    


  24. VOLPE FM
    Cause or consequence?
    Eur Respir J. 2022;59.
    PubMed    


    May 2022
  25. WOEHLK C, Von Bulow A, Ghanizada M, Baastrup Sondergaard M, et al
    Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study.
    Eur Respir J. 2022 May 26. pii: 13993003.00446-2022.
    PubMed     Abstract available


  26. SUN Y, Zhang M, Ou Z, Meng Y, et al
    Indoor microbiome, microbial and plant metabolites, chemical compounds and asthma symptoms in junior high school students: a multicentre association study in Malaysia.
    Eur Respir J. 2022 May 26. pii: 13993003.00260-2022.
    PubMed     Abstract available


  27. HABENER A, Grychtol R, Gaedcke S, DeLuca D, et al
    IgA(+) memory B cells are significantly increased in patients with asthma and small airways dysfunction.
    Eur Respir J. 2022 May 20. pii: 13993003.02130-2021.
    PubMed     Abstract available


  28. KROES JA, Zielhuis SW, De Jong K, Hashimoto S, et al
    Cumulative Corticosteroid Sparing Effect of Anti-Interleukin-5/5Ra In Eosinophilic Asthma.
    Eur Respir J. 2022 May 20. pii: 13993003.02983-2021.
    PubMed     Abstract available


  29. GAIETTO K, Han YY, Forno E, Bacharier LB, et al
    Violence-related distress and lung function in two longitudinal studies of youth.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    April 2022
  30. RABE KF, Pavord ID, Castro M, Wechsler ME, et al
    Dupilumab efficacy and safety in patients with asthma and blood eosinophils >/=500 cells.microL(-1).
    Eur Respir J. 2022 Apr 29. pii: 13993003.02577-2021.
    PubMed    


  31. VAN MEEL ER, Mensink-Bout SM, den Dekker HT, Ahluwalia TS, et al
    Early-life respiratory tract infections and the risk of school-age lower lung function and asthma: a meta-analysis of 150 000 European children.
    Eur Respir J. 2022 Apr 29. pii: 13993003.02395-2021.
    PubMed     Abstract available


  32. MENSINK-BOUT SM, van Meel ER, de Jongste JC, Annesi-Maesano I, et al
    Maternal diet in pregnancy and child's respiratory outcomes: an individual participant data meta-analysis of 18 000 children.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


  33. SINGH D, Beier J, Astbury C, Belvisi MG, et al
    The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    March 2022
  34. THOMAS D, McDonald VM, Pavord ID, Gibson PG, et al
    Asthma remission- what is it and how can it be achieved?
    Eur Respir J. 2022 Mar 31. pii: 13993003.02583-2021.
    PubMed     Abstract available


  35. HUYNH C, Whitmore GA, Vandemheen KL, FitzGerald JM, et al
    Derivation and Validation of the UCAP-Q Case-finding Questionnaire to Detect Undiagnosed Asthma and COPD.
    Eur Respir J. 2022 Mar 24. pii: 13993003.03243-2021.
    PubMed     Abstract available


  36. HAN YY, Yan Q, Chen W, Celedon JC, et al
    Child maltreatment, anxiety and depression, and asthma among British adults in the UK Biobank.
    Eur Respir J. 2022 Mar 17. pii: 13993003.03160-2021.
    PubMed     Abstract available


  37. BAL C, Idzko M, Skrgat S, Koch A, et al
    FeNO is associated with disease burden in the German Asthma Net severe asthma cohort.
    Eur Respir J. 2022 Mar 10. pii: 13993003.01233-2021.
    PubMed    


  38. KLEIN DK, Silberbrandt A, Frossing L, Hvidtfeldt M, et al
    Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma.
    Eur Respir J. 2022 Mar 2. pii: 13993003.02446-2021.
    PubMed     Abstract available


  39. VONK JM, Roukema J
    Air pollution susceptibility in children with asthma and obesity: tidal volume as key player?
    Eur Respir J. 2022;59.
    PubMed    


  40. THAMRIN C, Robinson PD, Farah CS, King GG, et al
    Technical standards for respiratory oscillometry and bronchodilator response cut-offs.
    Eur Respir J. 2022;59.
    PubMed    


  41. DAGHER R, Kumar V, Copenhaver AM, Gallagher S, et al
    Novel mechanisms of action contributing to benralizumab's potent anti-eosinophilic activity.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    February 2022
  42. MAISON N, Omony J, Illi S, Thiele D, et al
    T-high asthma phenotypes across life span.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02288-2021.
    PubMed     Abstract available


  43. ALI GB, Lowe AJ, Perret JL, Walters EH, et al
    Impact of lifetime body mass index trajectories on the incidence and persistence of adult asthma.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02286-2021.
    PubMed     Abstract available


  44. MORTIMER K, Reddel HK, Pitrez PM, Bateman ED, et al
    Asthma management in low- and middle-income countries: case for change.
    Eur Respir J. 2022 Feb 24. pii: 13993003.03179-2021.
    PubMed     Abstract available


  45. MORTIMER K, Lesosky M, Garcia-Marcos L, Innes Asher M, et al
    The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02865-2021.
    PubMed     Abstract available


  46. MOSLEMI A, Kontogianni K, Brock J, Wood S, et al
    Differentiating COPD and Asthma using Quantitative CT Imaging and Machine Learning.
    Eur Respir J. 2022 Feb 24. pii: 13993003.03078-2021.
    PubMed     Abstract available


  47. LOUIS R, Satia I, Ojanguren I, Schleich F, et al
    European Respiratory Society Guidelines for the Diagnosis of Asthma in Adults.
    Eur Respir J. 2022 Feb 15. pii: 13993003.01585-2021.
    PubMed     Abstract available


  48. SKOV IR, Madsen H, Henriksen DP, Andersen JH, et al
    Low dose oral corticosteroids in asthma associates with increased morbidity and mortality.
    Eur Respir J. 2022 Feb 10. pii: 13993003.03054-2021.
    PubMed     Abstract available


  49. GARCIA-MARCOS L, Innes Asher M, Pearce N, Ellwood E, et al
    The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study.
    Eur Respir J. 2022 Feb 10. pii: 13993003.02866-2021.
    PubMed     Abstract available


  50. TAYTARD J, Koskas M, Beydon N
    Spirometry forced expiratory time is driven by airflow limitation in asthmatic children.
    Eur Respir J. 2022 Feb 10. pii: 13993003.02620-2021.
    PubMed    


  51. MARCON A, Locatelli F, Accordini S
    The coexistence of asthma and COPD: some considerations about prevalence and lung function decline.
    Eur Respir J. 2022 Feb 3. pii: 13993003.00096-2022.
    PubMed    


  52. KEARNS N, Bruce P, Williams M, Doppen M, et al
    Repeated dose budesonide/formoterol compared to salbutamol in adult asthma: A randomised cross-over trial.
    Eur Respir J. 2022 Feb 3. pii: 13993003.02309-2021.
    PubMed     Abstract available


  53. SEYS SF, Long MB
    The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm.
    Eur Respir J. 2022;59.
    PubMed    


    January 2022
  54. PARASKAKIS E, Sarikloglou E, Fouzas S, Steiropoulos P, et al
    Improved prediction of asthma exacerbations by measuring distal airway inflammation.
    Eur Respir J. 2022 Jan 27. pii: 13993003.01684-2021.
    PubMed    


  55. GAUVREAU GM, Davis BE, Scadding G, Boulet LP, et al
    Allergen Provocation Tests in Respiratory Research: Building on 50 Years of Experience.
    Eur Respir J. 2022 Jan 27. pii: 13993003.02782-2021.
    PubMed     Abstract available


  56. RICCARDI D, Ward JP, Yarova PL, Janssen LJ, et al
    Topical therapy with negative allosteric modulators of the calcium-sensing receptor (calcilytics) for the management of asthma: the beginning of a new era?
    Eur Respir J. 2022 Jan 20. pii: 13993003.02103-2021.
    PubMed     Abstract available


  57. AL-SHAIKHLY T, Murphy RC, Parker A, Lai Y, et al
    Location of eosinophils in the airway wall is critical for specific features of airway hyperresponsiveness and T2 inflammation in asthma.
    Eur Respir J. 2022 Jan 13. pii: 13993003.01865-2021.
    PubMed     Abstract available


  58. PEROTIN JM, Wheway G, Tariq K, Azim A, et al
    Vulnerability to acid reflux of the airway epithelium in severe asthma.
    Eur Respir J. 2022 Jan 7. pii: 13993003.01634-2021.
    PubMed     Abstract available


  59. RAMIS J, Middlewick R, Pappalardo F, Cairns JT, et al
    Lysyl oxidase-like 2 is increased in asthma and contributes to asthmatic airway remodelling.
    Eur Respir J. 2022 Jan 7. pii: 13993003.04361-2020.
    PubMed     Abstract available


  60. BENSON VS, Hartl S, Barnes N, Galwey N, et al
    Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    December 2021
  61. RAITA Y, Perez-Losada M, Freishtat RJ, Hahn A, et al
    Nasopharyngeal metatranscriptome profiles of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study.
    Eur Respir J. 2021 Dec 16. pii: 13993003.02293-2021.
    PubMed     Abstract available


  62. PORSBJERG C, Nieto-Fontarigo JJ, Cerps S, Ramu S, et al
    Phenotype and severity of asthma determines bronchial epithelial immune responses to a viral mimic.
    Eur Respir J. 2021 Dec 16. pii: 13993003.02333-2021.
    PubMed     Abstract available


  63. AGARWAL R, Muthu V
    Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.
    Eur Respir J. 2021 Dec 9. pii: 13993003.02989-2021.
    PubMed    


  64. HAVETTE A, Regard L, Roche N, Burgel PR, et al
    Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma: is the benefit worth the risk?
    Eur Respir J. 2021 Dec 9. pii: 13993003.02924-2021.
    PubMed    


  65. KRUIZINGA MD, Essers E, Stuurman FE, Yavuz Y, et al
    Clinical validation of digital biomarkers for pediatric patients with asthma and cystic fibrosis - Potential for clinical trials and clinical care.
    Eur Respir J. 2021 Dec 9. pii: 13993003.00208-2021.
    PubMed     Abstract available


  66. GURDENIZ G, Ernst M, Rago D, Kim M, et al
    Neonatal metabolome of cesarean section and risk of childhood asthma.
    Eur Respir J. 2021 Dec 9. pii: 13993003.02406-2021.
    PubMed     Abstract available


  67. RYAN D, Sabroe I
    Identifying and addressing health inequalities in asthma care.
    Eur Respir J. 2021;58.
    PubMed    


  68. PAPAIOANNOU AI, Photiades A, Gaga M
    Using placebo-controlled trials to define predictors of future exacerbations in severe asthma patients.
    Eur Respir J. 2021;58.
    PubMed    


  69. PARK S, Lee S, Kim Y, Cho S, et al
    Kidney function and obstructive lung disease: a bidirectional Mendelian randomisation study.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    November 2021
  70. ABDEL-AZIZ MI, Vijverberg SJH, Neerincx AH, Brinkman P, et al
    A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes.
    Eur Respir J. 2021 Nov 25. pii: 13993003.02603-2021.
    PubMed    


  71. REINKE SN, Naz S, Chaleckis R, Gallart-Ayala H, et al
    Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study.
    Eur Respir J. 2021 Nov 25. pii: 13993003.01733-2021.
    PubMed     Abstract available


  72. MIKUS MS, Kolmert J, Andersson LI, Ostling J, et al
    Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation.
    Eur Respir J. 2021 Nov 4. pii: 13993003.00142-2021.
    PubMed     Abstract available


  73. OLIVER BG
    Food for thought: why is there more airway smooth muscle in asthma?
    Eur Respir J. 2021;58.
    PubMed    


  74. MANNINO DM
    Asthma, COPD and their overlap: coexistence or something more?
    Eur Respir J. 2021;58.
    PubMed    


    October 2021
  75. PIJNENBURG MW, Frey U, De Jongste JC, Saglani S, et al
    Childhood asthma- pathogenesis and phenotypes.
    Eur Respir J. 2021 Oct 28. pii: 13993003.00731-2021.
    PubMed     Abstract available


  76. ELSEY L, Pantin T, Holmes LJ, Tavernier G, et al
    Outcomes over the first two years of treatment with mepolizumab in severe asthma.
    Eur Respir J. 2021 Oct 28. pii: 13993003.01313-2021.
    PubMed     Abstract available


  77. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
    Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.
    Eur Respir J. 2021 Oct 19. pii: 13993003.02730-2021.
    PubMed     Abstract available


  78. CHAN R, Misirovs R, Lipworth B
    Repeatability of impulse oscillometry in patients with severe asthma.
    Eur Respir J. 2021 Oct 8. pii: 13993003.01679-2021.
    PubMed    


  79. SUN Y, Xia PF, Xie J, Mustieles V, et al
    Association of blood trihalomethane concentrations with asthma in U.S. adolescents: nationally representative cross-sectional study.
    Eur Respir J. 2021 Oct 8. pii: 13993003.01440-2021.
    PubMed     Abstract available


  80. PORSBJERG C, Maitland-van der Zee AH, Brusselle G, Canonica GW, et al
    3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.
    Eur Respir J. 2021;58.
    PubMed    


    September 2021
  81. MIURA S, Iwamoto H, Omori K, Yamaguchi K, et al
    Accelerated decline in lung function in adults with a history of remitted childhood asthma.
    Eur Respir J. 2021 Sep 29. pii: 13993003.00305-2021.
    PubMed     Abstract available


  82. BATEMAN ED, Price DB, Wang HC, Khattab A, et al
    Short-acting beta2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study.
    Eur Respir J. 2021 Sep 24. pii: 13993003.01402-2021.
    PubMed     Abstract available


  83. BUSBY J, Matthews JG, Chaudhuri R, Pavord ID, et al
    Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
    Eur Respir J. 2021 Sep 24. pii: 13993003.00768-2021.
    PubMed     Abstract available


  84. PANAGOU P, Tzilas V, Bouros D
    "Dynamic (C dyn) lung compliance in non-smokers with asthma and fixed, non-reversible airflow obstruction" ERJ 2021 58: 2004400.
    Eur Respir J. 2021 Sep 24. pii: 13993003.02361-2021.
    PubMed    


    April 2021
  85. ESTEVES P, Blanc L, Celle A, Dupin I, et al
    Crucial role of fatty acid oxidation in asthmatic bronchial smooth muscle remodelling.
    Eur Respir J. 2021 Apr 8. pii: 13993003.04252-2020.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: